A systematic approach that views the clinical research department as an integral part of the development team can enhance the likelihood of success in the creation of new products. Nancy J. Stark Many ...
HOLLISTON, Mass., May 31, 2023 (GLOBE NEWSWIRE) -- Biostage, Inc. (OTCQB: BSTG) (“Biostage” or the “Company”), a clinical-stage biotechnology company developing the technology to regenerate organs ...
LONDON & PALO ALTO, Calif.--(BUSINESS WIRE)--Cancer Research UK, one of the world’s largest charitable funders of cancer research, its innovation unit, Cancer Research Horizons, and Guardant Health, ...
The U.S. Food and Drug Administration (FDA) issued this week three guidance documents related to clinical trials: a draft guidance on multiregional trials in oncology, a draft guidance on integrating ...
Slope, provider of an eClinical Supply Chain Management platform, was recognized among ten vendors for Clinical Trial Resource Management in the 2022 report SAN FRANCISCO, Sept. 22, 2022 /PRNewswire/ ...
BOSTON--(BUSINESS WIRE)--eClinical Solutions, a global provider of digital clinical software and services, today announced it has been named as a 2022 Gartner® Hype Cycle for Life Science Clinical ...
Good day, everyone, and welcome to Pfizer Pflash, a spotlight on the PD-1 VEGF bispecific PF-4404 clinical development strategy. Today's call is being recorded. At this time, I would like to turn the ...
With the continuing cuts to US Food and Drug Administration (FDA) staffing, the pharmaceutical and biotechnology industries are communicating increasing concern about potential product development ...
Zacks Small Cap Research on MSN
QNRX: With Clinical Activities Expanding, QNRX Expects Cash Runway Into 2Q26
Quoin Pharmaceuticals (NASDAQ:QNRX), a clinical stage, specialty pharmaceutical company that focuses on developing treatments for rare and orphan diseases, is expanding clinical activities studying ...
Kymera Therapeutics has announced that Sanofi will advance their next-generation oral IRAK4 degrader, KT-485, into clinical testing, while opting not to pursue KT-474. Preclinical studies indicated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results